![](/img/cover-not-exists.png)
Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era [Corrigendum]
Krivak, Thomas, Smith, Ashlee, Zorn, Kristin, Sukumvanich, Paniti, Olawaiye, Alexander, Kelley, Joseph, Berger, JessicaLanguage:
english
Journal:
OncoTargets and Therapy
DOI:
10.2147/OTT.S80592
Date:
March, 2015
File:
PDF, 104 KB
english, 2015